Bloomios Inc (BLMS)

[Trading_bandit]

Yep. Its over

[builder101]

Not looking good here at this point.

https://www.otcmarkets.com/filing/html?id=17353038&guid=_3d-kn4eJqrDEhh

[Trading_bandit]

That was one hell of a pump and dump...wow...went from 0.0160 to now 0.0048 with less then 5k$ traded

[builder101]

I would like to see us get back up to that level shortly.

[Zardiw]

He's on the S-1 and OTCM .....what makes you think he's not listed.........

Z

[Zardiw]

Yeah, but the proposed price is .15 ......

Z

[Zardiw]

You think that's why they're running her today?

Z

[aljafy]

Anybody know why Barrett is no longer listed as an officer here?

[hondaboost]

Warning; BLMS, diluting 225 Million shares:

https://www.otcmarkets.com/filing/html?id=16738703&guid=MOg-kqt7kD7fJth

[builder101]

Nice day yesterday. Let’s see if we can continue today!

[RammageRaul]

I feel like an archeologists reading all this ancient posts left by early pumpers ROFL

[TommyBoyTrader9460]

$BLMS up 41 percent on very strong volume..hitting radars over the weekend..

[TommyBoyTrader9460]

$BLMS Added today with volume spike..could be a rocket..

[thetruth33]

A good read here. Take a look: https://cannabisindustryjournal.com/column/fly-by-night-do-your-gummies-take-the-red-eye/ $BLMS

[aljafy]

https://www.prnewswire.com/news-releases/bloomios-reports-2021-revenue-at-record-8-5-million-up-from-1-3-million-in-2020--301527930.html

[aljafy]

DRYWORLD Struts into Multi-Billion Dollar CBD Market

https://www.globenewswire.com/news-release/2022/03/31/2414392/0/en/DRYWORLD-Struts-into-Multi-Billion-Dollar-CBD-Market.html

[adijas]

Bloomios Shareholder Update & Growth Strategy

SANTA BARBARA, Calif., Nov. 17, 2021 /PRNewswire/ -- Bloomios, Inc. (OTC: BLMS), CEO, Michael Hill issued the following letter to shareholders, providing an update on the Company's developments and future growth strategy.


Bloomios Shareholder Update & Growth Strategy

Dear Shareholders, It is with immense pride that I present this update on our recent corporate activities and strategic initiatives to you.

Bloomios went public in April 2021. Bloomios was founded with the belief that high quality and affordable hemp-derived products should be accessible to those in the U.S. who need it to improve their daily activities. We are determined to become the leading hemp-derived products manufacturer, supporting the industry's most recognized brands.

Bloomios manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products via wholesale distribution channels, manufactured by its wholly owned subsidiary Bloomios Private Label. We provide services including custom formulation, brand development and order fulfillment to a wide variety of customers including both large and small brands, chain stores, vape shops and distributors. We offer our private-label and white-label customers a large array of custom formulations and manufacturing services with over 220 hemp products across 12 categories.

Bloomios' recent financings and cashflow have provided for the Company's acquisition of new software and hardware to further improve our manufacturing capabilities and our operational efficiencies. More specifically, the Company purchased a new infused gummy machine, a new high-production printer, additional packaging equipment, software systems and many other items. This expansion and automation should allow the Company to increase output by 3-5 times our current manufacturing capabilities. We also continue to bolster our management team and now have 70 full-time employees.

Bloomios believes that our first full year in operation, we will hit approximately $9 million in Gross Revenue and likely breakeven or have a small loss.

Additionally, Bloomios is focused on the vertical integration of targeted brand acquisitions enabling us to address the wider consumer direct market. Through the addition of brand acquisitions, organic development, and distribution channel partnerships we intend to offer a full suite of high-quality consumer products. The Company is currently conducting due diligence on several acquisition targets.

The Bloomios management team is committed to continuing to execute our growth and acquisition strategy to increase long term shareholder value by building profitable revenue.

We value all our shareholders. If you have any questions or concerns, please do not hesitate to contact us at the following address: [e-mail]

[Renee]

XLR Medical Corp., XLRM, changed to Bloomios Inc., BLMS:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[i will make you rich]

Back Green! Who would sell on a spread like that lol

[allezlOM]

Curious to see what kind of merger will come with new ceo Bryan S. Glass ?

[FastBuxJones]

Let's clean the board up a little bit. Less talk. . . This is not even the next stock to move

[Train.Bull]

Terra Nuva, does kicko need more people post in ihub. Let mr know. I used to be paid by papastocks to post in ihub. Does kicko pay you?

[Nazar3]

You work for Kicko do not post your program on here.

[FastBuxJones]

I like that

[lowfloatmaster]

Love the recent 500k os update
My fav lol

[Terra Nuva]

XLRM Found on OTCre SOS Filing Scanner First ->

Link

[LowFloatLopes]

Damnit! cto for me

[adijas]

Reinstated by Bryan Glass https://www.nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=CjQ2xTaDYG1GVq3ABfOWZg%253d%253d&CorpName=XLR+MEDICAL+CORP.

[FastBuxJones]

Sweet

[Nazar3]

Don’t ask questions.

[mrs trader]

I am going to give them a call tomorrow to see if there still doing business.

[mrs trader]

Is anyone following the company?

[mrs trader]

I wonder what there story is.

[mrs trader]

I cant even remember when this company had any news